Filter articles using the following links

Future is now: Leaders in Ocular Gene Therapy Meeting, San Francisco (CA)

GenSight Biologics reports sustained efficacy and safety at 96 weeks in RESCUE Phase III clinical trial of GS010 for the treatment of Leber Hereditary Optic Neuropathy (LHON)

Ophthalmology Innovation Summit @ AAO, San Francisco (CA)

American Academy of Ophthalmology, San Francisco (CA)

EURETINA 2019 Congress, Paris, France

2019 Annual Meeting ASRS, Chicago, IL (US)

GenSight Biologics Reports Interim Financial Results for the First Half of 2019 and Provides Operational Update

GenSight Biologics completes enrollment of GS010 REFLECT Phase III trial in the treatment of Leber Hereditary Optic Neuropathy ahead of schedule

UMDF Mitochondrial Medicine 2019, Washington DC, US

GenSight Biologics expands its Board of Directors with the appointments of Maritza McIntyre and Sofinnova Partners